Published on: Wednesday, May 05, 2021
By: Bernama
Text Size:
PUTRAJAYA: The Health Ministry (MOH) will constantly monitor the incidence of blood clots with the administration of the AstraZeneca Covid-19 vaccine and gives an assurance of immediate treatment in the event of such an incident occurring, said Health Minister Datuk Seri Dr Adham Baba
(pic).
“The occurrence of blood clots is very rare, and the administration of this vaccine has taken into account its benefits in preventing Covid-19 infection, which outweighs the risks from vaccination,” he said in a statement Tuesday.
Malaysia received 268,800 doses of Covid-19 AstraZeneca vaccine through the Covax Facility on April 24, and the vaccine will be administered to members of the public tomorrow.
PUTRAJAYA: The Health Ministry (MOH) will constantly monitor the incidence of blood clots with the administration of the AstraZeneca Covid-19 vaccine and assures the public that immediate treatment will be given should such an incident occur.
“The occurrence of blood clots is very rare, and the administration of this vaccine has taken into account its benefits in preventing Covid-19 infection, which outweighs the risks from vaccination, ” said Health Minister Datuk Seri Dr Adham Baba in a statement.
Malaysia received 268,800 doses of AstraZeneca Covid-19 vaccine through the Covax facility on April 24, and the vaccine will be administered to the public from today.
What to do after your first AstraZeneca vaccine dose Share
Have you signed up for your Covid-19 vaccine yet? According to World Health Organization, vaccines are a critical new tool in the battle against COVID-19.
“It is hugely encouraging to see so many vaccines proving successful and going into development. Working as quickly as they can, scientists from across the world are collaborating and innovating to bring us tests, treatments and vaccines that will collectively save lives and end this pandemic,” it says.
For those who recently signed up for the AstraZeneca Covid-19 vaccine opt-in programme, Health Minister Datuk Seri Dr Adham Baba, in an official statement issued by Ministry of Health on May 4, says the ministry will constantly monitor the incidence of blood clots with the administration of the vaccine. He also gives an assurance of immediate treatment in the event of such an incident occurring.
Tuesday, 04 May 2021 05:43 PM MYT
Malaysia received 268,800 doses of AstraZeneca Covid-19 vaccine through the Covax Facility on April 24, and the vaccine will be administered to members of the public tomorrow. AFP pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
PUTRAJAYA, May 4 The Health Ministry (MOH) will constantly monitor the incidence of blood clots with the administration of the AstraZeneca Covid-19 vaccine and gives an assurance of immediate treatment in the event of such an incident occurring, said Health Minister Datuk Seri Dr Adham Baba.
“The occurrence of blood clots is very rare, and the administration of this vaccine has taken into account its benefits in preventing Covid-19 infection, which outweighs the risks from vaccination,” he said in a statement today.
FILE PHOTO: Vials of Oxford/AstraZeneca s COVID-19 vaccine are pictured at a vaccination centre in Bierset, Belgium March 17,2021. REUTERS/Yves Herman
PUTRAJAYA (Bernama): The Health Ministry will constantly monitor the incidence of blood clots with the administration of the AstraZeneca Covid-19 vaccine and will give immediate treatment if such an event occurs, says Health Minister Datuk Seri Dr Adham Baba. The occurrence of blood clots is very rare, and the administration of this vaccine has taken into account its benefits in preventing COVID-19 infection, which outweighs the risks from vaccination, ” he said in a statement today.
Malaysia received 268,800 doses of the AstraZeneca Covid-19 vaccine through the COVAX Facility on April 24, and the vaccine will be administered to people who registered tomorrow.